Crossmark

PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease

Crossref DOI link: https://doi.org/10.1007/s10620-016-4440-7

Published Online: 2017-01-23

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fuller, Garth

Bolus, Roger

Whitman, Cynthia

Talley, Jennifer

Erder, M. Haim

Joseph, Alain

Silberg, Debra G.

Spiegel, Brennan
Funding

Funding for this research was provided by:

Shire-Movetis NV.
License Information

License valid from 2017-01-23